Navigation Links
NovaRx Appoints Industry Veteran as President and COO
Date:12/4/2008

to be a safe and effective treatment for lung cancer patients. My clear priority is to ensure the Phase III study is executed flawlessly. In addition, I will be searching to find the best commercialization partner for Lucanix(R) while growing our tremendous pipeline of new product opportunities."

About NovaRx

Founded in 1997, NovaRx Corporation is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel cell-based therapeutic vaccines for the treatment of cancer. The company's 24,000 square foot headquarters in San Diego, CA, house corporate offices and manufacturing operations. The proprietary core technology upon which Lucanix(R) is based has been exclusively licensed to NovaRx on a worldwide basis. Lucanix(R) is a registered trademark of NovaRx Corporation.

NovaRx's lead product candidate, Lucanix(R), a whole cell-based therapeutic vaccine comprised of four allogeneic cell lines, has completed a Phase II clinical trial for the treatment of progressive non-small cell lung cancer.

Lucanix(R), which was utilized in that Phase II trial to treat advanced stage NSCLC patients (stages IIIB and IV) who had received zero to five prior chemotherapies, demonstrated a one-year survival of 61% and a two-year survival of 41%, and a median survival of 16 months. These late-stage patients typically demonstrate a less than 30% one-year survival. Typical two year survival for stage IV patients is 5% and for stage IIIB is 10% on average. Currently, 59% of the patients who received Lucanix(R) following one frontline regimen of chemotherapy and entered the trial with stable disease have lived over 41 months. Of the patients enrolled in the trial who are still alive, all have lived more than three years, ten have lived more than four years, and three have lived over five years.

Most importantly, Lucanix(R) demonstrated no sig
'/>"/>

SOURCE NovaRx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
2. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
3. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
4. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
5. Curemark Appoints Preeminent Pediatrics Gastroenterologist
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. West Pharmaceutical Services, Inc. Appoints New Director
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
10. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
11. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
(Date:7/28/2014)... 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... second quarter 2014 financial results for the period ended June ... PDL,s management will host a conference call and webcast that ... results.  A slide presentation relating to the call will be ... Conference Call Details To access the live conference ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
Breaking Medicine Technology:OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, 2014 (HealthDay ... -- as mandated under the Affordable Care Act -- could ... deny insurance coverage for any medical practice that violates their ... experts counter that such predictions are unlikely to come true. ... Stores Inc. and Conestoga Wood Specialties Corp. did not have ...
(Date:7/28/2014)... 28, 2014 This is a ... Chinese Tadalafil industry. The report firstly reviews the ... and manufacturing technology. The report then explores global ... product specification, capacity, Production value, and market share ... global and China’s total market of Tadalafil by ...
(Date:7/28/2014)... Carolina (PRWEB) July 28, 2014 The ... their first bite of food best, with each subsequent ... the researchers found, can actually serve to sabotage the ... in foods they enjoy, not realizing the effect," Baba ... is the argument for moderation, if we needed one. ...
(Date:7/28/2014)... July 28, 2014 H2T Elite Dryland Training ... Located at 573 Alness Street in Toronto, H2T ... of Steeles. H2T is a state of the art facility ... seniors. There are many gyms out there for people 18 ... seniors alone. H2T will be home to many elite athletes ...
(Date:7/28/2014)... Sussex, Wisconsin (PRWEB) July 28, 2014 ... to help First Lady Michelle Obama and Partnership for ... new organizations as they join the group's DrinkUP ... drink more water, more often. , The seven ... Haws Corporation™, Nalgene® Outdoor Products, S’well Bottle, Santa Clara ...
Breaking Medicine News(10 mins):Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 4Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 5Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 4Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:FS Local Community Member H2T Elite Dryland Training Is Set to Open Its Doors 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3
... EAST RUTHERFORD, N.J., June 4 Cambrex Corporation (NYSE: ... from the New York Stock Exchange ("NYSE") informing the Company ... listing standards. As announced by the Company on April ... continued listing standards because its average market capitalization over a ...
... 4 NxStage Medical, Inc. (Nasdaq: NXTM ), ... Jeffrey H. Burbank, Chief Executive Officer, will be presenting at ... 2009 at The Four Seasons Hotel in Chicago, IL. ... June 9th at 4:30 p.m. (CST). To listen to ...
... potentially deadly conditions , THURSDAY, June 4 (HealthDay News) ... and forms a scab after a cut? Researchers have ... , "The human body has an incredible ability to ... P. Wong, a principal investigator at the Rowland Institute ...
... Latino Pennsylvanians , , HARRISBURG, Pa., June 4 ... of Estoydecidido.com , a resource tool to help ... Estoydecidido.com -- which translates to "I am determined" ... DeterminedToQuit.com site. , , "Latinos have become ...
... Laboratories, Inc., a leading research-based contract manufacturer of intermediates, ... pleased to announce the issuance by the Tianjin branch ... a manufacturing certificate for drug products to our Tianjin ... dosage forms including tablets, capsules, and pellets. , ...
... , , CLEVELAND, June 4 In ... of six selected to the International Factoring Association Advisory Board. ... Cohen will be asked to provide guidance and feedback to ... board members, Mr. Cohen will also be responsible for communicating ...
Cached Medicine News:Health News:NxStage to Present at the William Blair Growth Stock Conference 2Health News:Researchers Detect Blood-Clotting Mechanism 2Health News:Pennsylvania Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Asymchem Announces sFDA Certification for Drug Product Manufacturing 2Health News:President of PRN Funding Appointed to Factoring Association Advisory Board 2
... TCS Symphony orchestrates images and patient ... and information sources in one central ... workflow and improves cost-effectiveness so that ... they do best, helping people., ,Many ...
... Bright quartz halogen illumination with ... filter for whiter light Worldwide ... controlled fan keeps unit coo. ... change Optional tray will clamp ...
... Lite positions directly over one,eye permitting ... lens an exclusive feature ,resulting ... optic light that penetrates,deep into a ... swivel mount enables the,surgeon to rotate ...
Mounted on a remarkably lightweight and,flexible cotton headband with crown strap,the Sport is fully adjustable....
Medicine Products: